P19: BASELINE CORRELATES OF COMPLETE RESPONSE TO IDECABTAGENE VICLEUCEL (IDE‐CEL, BB2121), A BCMA‐DIRECTED CAR T CELL THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF THE KARMMA TRIAL.

Details

Language :

English

ISSN :

25729241

Volume :

6

Database :

Complementary Index

Journal :

HemaSphere

Publication Type :

Academic Journal

Accession number :

175235229

Full Text :

https://doi.org/10.1097/01.HS9.0000829648.85784.e2